Many types of arthritis are present in up to twenty per cent of the region’s population, affecting individuals of all ages. The most common forms are osteoarthritis, rheumatoid arthritis and spondylitis. Usually considered a condition of the old and frail, joint inflammation is increasingly affecting younger people, including juvenile rheumatoid arthritis. Vitamin D deficiency, caused by lack of exposure to direct sunlight, affects up to 80% of the region’s population. This contributes to muscle and bone weakness, which in turn makes the body more vulnerable to arthritis and osteoporosis. Pharmax will produce a full range of medication to support the region’s rheumatologists and orthopedic specialists.

Product will be updated

Copyright 2020 – Pharmax Pharmaceuticals FZ-LLC. All Rights Reserved.

Ministry of Health Health and Prevention Advertisement License No : IN0W3681-140720 valid till 15/07/2021